The number of p53-positive cells was significantly lower in the tumors treated with 50 μM TMZ compared with the T98G-control, and treatment with 3 mM NaDCA or 2 mM VPA–3 mM NaDCA did not affect the expression of p53 in the T98G tumor compared to the control. The gene discussed is TP53; the disease is neoplasm.